Large Clinical Trial Suggests NIPT Better at Detecting Fetal Trisomy than First Trimester Screening | GenomeWeb

In a head-to-head comparison of noninvasive prenatal testing to standard first trimester screening for detecting Down syndrome, researchers found that analyzing cell-free DNA from maternal plasma comes out on top.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.